在印度孟买,对与药物敏感肺结核患者有家庭接触的人进行结核病感染检测和治疗。

Daksha Shah, Sampada Bhide, Rajesh Deshmukh, Jonathan P Smith, Satish Kaiplyawar, Varsha Puri, Vijay Yeldandi, Anand Date, Melissa Nyendak, Christine S Ho, Patrick K Moonan
{"title":"在印度孟买,对与药物敏感肺结核患者有家庭接触的人进行结核病感染检测和治疗。","authors":"Daksha Shah, Sampada Bhide, Rajesh Deshmukh, Jonathan P Smith, Satish Kaiplyawar, Varsha Puri, Vijay Yeldandi, Anand Date, Melissa Nyendak, Christine S Ho, Patrick K Moonan","doi":"10.3389/ftubr.2024.1454277","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Mumbai is one of the most densely populated areas in the world and is a major contributor to the tuberculosis (TB) epidemic in India. A test and treat approach for TB infection (TBI) amongst household contacts (HHC) is part of the national policy for TB preventive treatment (TPT). However, in practice, the use of interferon-gamma release assay (IGRA) tests for infection are limited, and prevalence of TBI in Mumbai is not known.</p><p><strong>Methods: </strong>We conducted a cross-sectional study among HHCs exposed to persons with microbiologically-confirmed, drug-susceptible pulmonary TB that were notified for antituberculosis treatment in Mumbai, India during September-December, 2021. Community-based field workers made home visits and offered IGRA (QuantiFERON-TB<sup>®</sup> Gold In-Tube Plus) tests to HHC aged 5 years and older. After ruling out active TB disease, HHC with IGRA-positive test results were referred for TPT. All HHC were monitored for at least 24 months for progression to active TB disease.</p><p><strong>Results: </strong>Among 502 HHCs tested, 273 (54%) had IGRA-positive results. A total of 254 (93%) were classified as TBI and were eligible for TPT, of which 215 (85%) initiated TPT, and 194 (90%) completed TPT successfully. There was substantial variation in rates of TBI per household. In 32% of households, all HHC (100%) were IGRA positive and in 64% of households >50% of HHC were infected. In all, 22 HHCs (4%; 22/558) were diagnosed with TB disease; of these, five HHC were diagnosed during follow up, of which three were IGRA positive and had no evidence of disease at initial screening but chose not to initiate TPT.</p><p><strong>Conclusion: </strong>A test and treat strategy for HHC resulted in the detection of a substantial proportion of TBI and secondary TB cases. Home-based IGRA testing led to high participation rates, clinical evaluations, TPT initiation, and early diagnoses of additional secondary cases. A community-focused, test and treat approach was feasible in this population and could be considered for broader implementation.</p>","PeriodicalId":101354,"journal":{"name":"Frontiers in tuberculosis","volume":"2 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11485165/pdf/","citationCount":"0","resultStr":"{\"title\":\"Test and treat approach for tuberculosis infection amongst household contacts of drug-susceptible pulmonary tuberculosis, Mumbai, India.\",\"authors\":\"Daksha Shah, Sampada Bhide, Rajesh Deshmukh, Jonathan P Smith, Satish Kaiplyawar, Varsha Puri, Vijay Yeldandi, Anand Date, Melissa Nyendak, Christine S Ho, Patrick K Moonan\",\"doi\":\"10.3389/ftubr.2024.1454277\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Mumbai is one of the most densely populated areas in the world and is a major contributor to the tuberculosis (TB) epidemic in India. A test and treat approach for TB infection (TBI) amongst household contacts (HHC) is part of the national policy for TB preventive treatment (TPT). However, in practice, the use of interferon-gamma release assay (IGRA) tests for infection are limited, and prevalence of TBI in Mumbai is not known.</p><p><strong>Methods: </strong>We conducted a cross-sectional study among HHCs exposed to persons with microbiologically-confirmed, drug-susceptible pulmonary TB that were notified for antituberculosis treatment in Mumbai, India during September-December, 2021. Community-based field workers made home visits and offered IGRA (QuantiFERON-TB<sup>®</sup> Gold In-Tube Plus) tests to HHC aged 5 years and older. After ruling out active TB disease, HHC with IGRA-positive test results were referred for TPT. All HHC were monitored for at least 24 months for progression to active TB disease.</p><p><strong>Results: </strong>Among 502 HHCs tested, 273 (54%) had IGRA-positive results. A total of 254 (93%) were classified as TBI and were eligible for TPT, of which 215 (85%) initiated TPT, and 194 (90%) completed TPT successfully. There was substantial variation in rates of TBI per household. In 32% of households, all HHC (100%) were IGRA positive and in 64% of households >50% of HHC were infected. In all, 22 HHCs (4%; 22/558) were diagnosed with TB disease; of these, five HHC were diagnosed during follow up, of which three were IGRA positive and had no evidence of disease at initial screening but chose not to initiate TPT.</p><p><strong>Conclusion: </strong>A test and treat strategy for HHC resulted in the detection of a substantial proportion of TBI and secondary TB cases. Home-based IGRA testing led to high participation rates, clinical evaluations, TPT initiation, and early diagnoses of additional secondary cases. A community-focused, test and treat approach was feasible in this population and could be considered for broader implementation.</p>\",\"PeriodicalId\":101354,\"journal\":{\"name\":\"Frontiers in tuberculosis\",\"volume\":\"2 \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11485165/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in tuberculosis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3389/ftubr.2024.1454277\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in tuberculosis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/ftubr.2024.1454277","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:孟买是世界上人口最稠密的地区之一,也是印度结核病(TB)流行的主要原因。对家庭接触者(HHC)中的结核病感染(TBI)进行检测和治疗是国家结核病预防性治疗(TPT)政策的一部分。然而,在实践中,使用干扰素-γ释放测定(IGRA)检测感染的情况很有限,孟买的 TBI 患病率也不清楚:我们对 2021 年 9 月至 12 月期间在印度孟买接触到微生物学确诊的、药物敏感性肺结核患者并被通知接受抗结核治疗的高危人群进行了横断面研究。社区现场工作人员进行家访,并为 5 岁及以上的 HHC 提供 IGRA(QuantiFERON-TB® Gold In-Tube Plus)检测。在排除活动性结核病的可能性后,IGRA 检测结果呈阳性的高危人群将被转介接受结核病治疗。对所有 HHC 进行至少 24 个月的监测,以确定其是否发展为活动性结核病:在接受检测的 502 名高危人群中,有 273 人(54%)的 IGRA 检测结果呈阳性。共有 254 人(93%)被归类为 TBI,符合接受 TPT 的条件,其中 215 人(85%)开始接受 TPT,194 人(90%)成功完成了 TPT。每个家庭的 TBI 比率差异很大。在 32% 的家庭中,所有高危人群(100%)的 IGRA 均呈阳性,在 64% 的家庭中,超过 50% 的高危人群受到感染。总共有 22 个高危人群(4%;22/558)被诊断出患有结核病;其中,5 个高危人群在随访期间被诊断出患有结核病,其中 3 个高危人群的 IGRA 呈阳性,在初筛时没有疾病迹象,但选择不进行结核病治疗:结论:针对高危人群的检测和治疗策略发现了很大一部分 TBI 和继发性肺结核病例。基于家庭的 IGRA 检测带来了高参与率、临床评估、TPT 启动以及更多继发性病例的早期诊断。以社区为重点的检测和治疗方法在这一人群中是可行的,可以考虑在更大范围内实施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Test and treat approach for tuberculosis infection amongst household contacts of drug-susceptible pulmonary tuberculosis, Mumbai, India.

Background: Mumbai is one of the most densely populated areas in the world and is a major contributor to the tuberculosis (TB) epidemic in India. A test and treat approach for TB infection (TBI) amongst household contacts (HHC) is part of the national policy for TB preventive treatment (TPT). However, in practice, the use of interferon-gamma release assay (IGRA) tests for infection are limited, and prevalence of TBI in Mumbai is not known.

Methods: We conducted a cross-sectional study among HHCs exposed to persons with microbiologically-confirmed, drug-susceptible pulmonary TB that were notified for antituberculosis treatment in Mumbai, India during September-December, 2021. Community-based field workers made home visits and offered IGRA (QuantiFERON-TB® Gold In-Tube Plus) tests to HHC aged 5 years and older. After ruling out active TB disease, HHC with IGRA-positive test results were referred for TPT. All HHC were monitored for at least 24 months for progression to active TB disease.

Results: Among 502 HHCs tested, 273 (54%) had IGRA-positive results. A total of 254 (93%) were classified as TBI and were eligible for TPT, of which 215 (85%) initiated TPT, and 194 (90%) completed TPT successfully. There was substantial variation in rates of TBI per household. In 32% of households, all HHC (100%) were IGRA positive and in 64% of households >50% of HHC were infected. In all, 22 HHCs (4%; 22/558) were diagnosed with TB disease; of these, five HHC were diagnosed during follow up, of which three were IGRA positive and had no evidence of disease at initial screening but chose not to initiate TPT.

Conclusion: A test and treat strategy for HHC resulted in the detection of a substantial proportion of TBI and secondary TB cases. Home-based IGRA testing led to high participation rates, clinical evaluations, TPT initiation, and early diagnoses of additional secondary cases. A community-focused, test and treat approach was feasible in this population and could be considered for broader implementation.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Comorbidity profiles among sputum-positive tuberculosis patients in Cameroon. A broader evaluation of vaccine-induced T cell immunity against tuberculosis Diverse interactions of Mycobacterium tuberculosis infection and of BCG vaccination with SARS-CoV-2 Case report: Congenital multidrug-resistant tuberculosis Test and treat approach for tuberculosis infection amongst household contacts of drug-susceptible pulmonary tuberculosis, Mumbai, India.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1